China Nepstar Chain Drugstore Ltd (NPD) 2.55 $NPD China

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
China Nepstar Chain Drugstore Ltd (NPD) 2.55 $NPD

China Nepstar Chain Drugstore Ltd. Announces Completion of Merger
PR Newswire - Wed Aug 03, 3:30PM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, announced today the completion of its merger (the "merger" with Neptunus Global Limited ("Merger Sub" , a wholly-owned subsidiary of China Neptunus Drugstore Holding Ltd. ("Parent" , pursuant to the agreement and plan of merger (the "merger agreement" dated March 16, 2016 by and among Parent, Merger Sub and the Company. As a result of the merger, the Company ceased to be a publicly traded company and became a wholly-owned subsidiary of Parent.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Announces Shareholders Vote to Approve Merger
PR Newswire - Fri Jul 29, 5:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, announced today that, at an extraordinary general meeting of the Company's shareholders held on July 29, 2016, the Company's shareholders voted in favor of, and passed a special resolution to approve, among others, the proposal to authorize and approve (i) the previously announced agreement and plan of merger (the "merger agreement" dated March 16, 2016 by and among China Neptunus Drugstore Holding Ltd. ("Parent" , Neptunus Global Limited ("Merger Sub" and the Company, pursuant to which Merger Sub will be merged with and into the Company with the Company continuing as the surviving company as a wholly-owned subsidiary of Parent after the merger (the "merger" , (ii) the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands, substantially in the form attached to the merger agreement (the "plan of merger" , and (iii) any and all transactions contemplated by the merger agreement, including the merger.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Announces Extraordinary General Meeting of Shareholders
PR Newswire - Wed Jun 22, 5:30AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, announced today that it has called an extraordinary general meeting of shareholders (the "EGM" , to be held at 10:00 a.m. Beijing Time on July 29, 2016, at the Company's office at 25F, Neptunus Yinhe Keji Building No.1, Kejizhong 3rd Road Nanshan District, Shenzhen, Guangdong Province, 518057, People's Republic of China, to consider and vote on, among other things, the proposal to authorize and approve the previously announced agreement and plan of merger (the "Merger Agreement" dated March 16, 2016, by and among China Neptunus Drugstore Holding Ltd. ("Parent" , Neptunus Global Limited ("Merger Sub" and the Company, the plan of merger required to be filed with the Registrar of Companies of the Cayman Islands, substantially in the form attached as Appendix I to the Merger Agreement (the "Plan of Merger" and the transactions contemplated thereby (including the Merger, as defined below).
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Reports First Quarter 2016 Financial Results
PR Newswire - Tue May 31, 3:52AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended March 31, 2016.
NPD: 2.55 (+0.01)

Investor Calendar Invites You to the China Nepstar Chain Drugstore First Quarter 2016 Earnings Conference Call on Tuesday, May 31, 2016
ACCESSWIRE - Fri May 27, 3:10PM CDT
SHENZHEN, CHINA / ACCESSWIRE / May 27, 2016 / China Nepstar Chain Drugstore Ltd. (NYSE: NPD) will host a conference call to discuss the results of the first quarter 2016, to be held Tuesday, May 31, 2016 at 8:00 AM Eastern Time.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore to Report First Quarter 2016 Financial Results on May 31, 2016
PR Newswire - Wed May 25, 3:14AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the Company will report its unaudited financial results for the first quarter of 2016 on May 31, 2016 before the market opens.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Filed 2015 Annual Report on Form 20-F
PR Newswire - Wed Apr 27, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced the Company filed its annual report on Form 20-F for the year ended December 31, 2015 with the Securities and Exchange Commission on April 26, 2016. The annual report can be accessed on the Company's investor relations website at http://ir.nepstar.cn. The Company will provide a hard copy of the annual report containing its audited financial statements for the year ended December 31, 2015, free of charge, to its shareholders and ADS holders upon request.
NPD: 2.55 (+0.01)

Investor Calendar Invites You to the China Nepstar Chain Drugstore Fourth Quarter and Fiscal Year 2015 Earnings Conference Call on Tuesday, March 29, 2016
ACCESSWIRE - Mon Mar 28, 3:07PM CDT
SHENZHEN, CHINA / ACCESSWIRE / March 28, 2016 / China Nepstar Chain Drugstore Ltd. (NYSE: NPD) will host a conference call to discuss the results of the fourth quarter and fiscal year 2015, to be held Tuesday, March 29, 2016 at 8:00 AM Eastern Time.
NPD: 2.55 (+0.01)

These China Focused Small Cap Stocks Have Interesting Growth Stories
ACCESSWIRE - Tue Nov 17, 7:00AM CST
MIAMI, FL / ACCESSWIRE / November 17, 2015 / China has been one of the most down-beat countries over the last few quarters with equities losing value across board. However, not everything about China is all bad, especially when looking at some of the most promising small cap plays traded in the US.
NPD: 2.55 (+0.01), CJJD: 1.95 (+0.03), LITB: 3.22 (-0.14)

China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results
PR Newswire - Wed Sep 02, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2015.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore to Report Second Quarter 2015 Financial Results on September 2, 2015
PR Newswire - Tue Aug 11, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the Company will report its unaudited financial results for the second quarter of 2015 on September 2, 2015 before the market opens.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Special Committee Retains Financial Advisor and Legal Counsel
PR Newswire - Thu Aug 06, 3:43AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the special committee (the "Special Committee" of the Company's board of directors has retained Houlihan Lokey (China) Limited as its financial advisor and Shearman & Sterling LLP as its United States legal counsel in connection with its review and evaluation of the previously announced preliminary non-binding "going private" proposal letter that the Company's board of directors received on July 6, 2015.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Announces Formation of Special Committee to Consider "Going Private" Proposal
PR Newswire - Fri Jul 17, 7:38PM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that its board of directors (the "Board" has formed a special committee consisting of three independent directors (the "Special Committee" , Mr. Barry J. Buttifant, Mr. Alistair Eric MacCallum Laband and Mr. Alan Au, to consider the previously announced preliminary non-binding "going private" proposal letter that the Board received on July 6, 2015. Mr. Barry J. Buttifant will chair the Special Committee. The Special Committee intends to retain independent legal and financial advisors to assist it in this process.
NPD: 2.55 (+0.01)

China Stock Roundup: Mindray Medical to Buy Remaining Stake in Dragonbio, Noah Holdings Announces Buyback - Analyst Blog
Swarup Gupta - Zacks Investment Research - Thu Jul 09, 3:36PM CDT
Markets had a dismal week, despite a series of measures taken by the government to boost markets.
NPD: 2.55 (+0.01), SOL: 1.14 (-0.03), NOAH: 26.28 (+0.10), PBR: 9.58 (+0.36), CEO: 123.29 (+2.65), SNP: 73.37 (+2.03), TSL: 10.49 (unch), MR: 27.94 (+0.07), PTR: 67.55 (+1.68), ZNH: 29.74 (+0.33), BABA: 99.25 (+1.83)

China Nepstar Chain Drugstore receives going private proposal at USD1.30 per share or USD2.60 per ADS in cash
M2 - Tue Jul 07, 3:38AM CDT
Retail drugstore China Nepstar Chain Drugstore (NYSE:NPD) said on Monday that its board of directors has received a preliminary non-binding proposal letter for the acquisition of all of the outstanding ordinary shares at USD1.30 per share and the American Depositary Shares at USD2.60 per ADS in cash in a going private transaction.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal
PR Newswire - Mon Jul 06, 2:49AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that its board of directors has received a preliminary non-binding proposal letter, dated July 6, 2015, from Simin Zhang, chairman of the board of directors of the Company, and China Neptunus Drugstore Holding Ltd., an investment vehicle wholly owned by Mr. Zhang("Neptunus Holding", and collectively with Mr. Zhang, the "Buyer Parties" , pursuant to which the Buyer Parties propose to acquire all of the outstanding ordinary shares (the "Shares" and the American Depositary Shares ("ADSs", each representing two Shares) of the Company, in both cases, that are not already beneficially owned by the Buyer Parties and their affiliates at a price of US$1.30 per Share or US$2.60 per ADS, as the case may be, in cash, in a going private transaction(the "Acquisition" , subject to certain conditions.
NPD: 2.55 (+0.01)

China Nepstar Chain Drugstore Up 9.5%, Shares Break Through Resistance (NPD)
Comtex SmarTrend(R) - Mon Jun 08, 11:47AM CDT
China Nepstar Chain Drugstore (NYSE:NPD) is one of today's best performing low-priced stocks, up 9.5% to $2.77 on 1.3x average daily volume. Thus far today, China Nepstar Chain Drugstore has traded 297,000 shares, vs. average volume of 230,000 shares per day. The stock has outperformed the Dow (9.5% to the Dow's -0.2%) and outperformed the S&P 500 (9.5% to the S&P's -0.3%) during today's trading.
NPD: 2.55 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MISUMI Americas Expands, Ventures into New Horizons

Updated Category News Views 119

Marking New Territory in Monterrey MISUMI Americas is planting a new flag down in Monterrey, Mexico, with a sprawling 45,000-square-foot facility. This isn't just another expansion; it's a strategic move that's bound to shake things up in the manufacturing sector south of the border. When you've got a player like MISUMI widening their footprint, it catches the eye. Why?...

Continue Reading
Neil deGrasse Tyson Headlines HIMSS27 with Cosmic Insights

Updated Category News Views 188

celebrated science communicator, is set to close out the HIMSS27 conference with a keynote that's bound to leave a lasting impression. It's a fitting intersection of stars and stethoscopes, as the astrophysicist brings his expansive lens to the nitty-gritty of healthcare innovation. Splicing Science with Storytelling Folks, this ain't your standard healthcare gathering....

Continue Reading
Sovereign Crown Vault's Auction Draws Numismatic Collectors

Updated Category News Views 82

A Legendary Auction with Three Generations of Passion Coins, eh? They might just be small metallic disks to the untrained eye, but these suckers tell stories that stretch beyond any bank ledger. Sovereign Crown Vault LLC knows this, and they’re gearing up for quite the show on November 22, 2026. Their Holiday Season Kickoff Spectacular is about to lure in collectors...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 88

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading
Gary Brecka's Longevity Centers Set to Launch with Impact

Updated Category News Views 114

A Footprint of Longevity in the Making It's not every day you see a name like Daymond John, of Shark Tank fame, getting his hands into the business of human longevity. But here we are, with Gary Brecka's Ultimate Longevity Center (ULC) getting ready to open its first centers come January 2027, in Arizona, Colorado, Florida, and Southern California. More than 300 U.S....

Continue Reading
SGRY Acquisition Under Scrutiny: Fairness Questioned

Updated Category News Views 185

Questions Hover Over SGRY Acquisition Here's a real jaw-dropper for you. Surgery Partners, Inc. (NASDAQ: SGRY) is getting clocks cleaned in a fairness probe over its acquisition terms. If you thought this ride was smooth, think again—Levi & Korsinsky, LLP has put the brakes on any such assumptions, launching an investigation that’s sure to raise some eyebrows. What's...

Continue Reading
MacKenzie-Childs Grinds Into Spotlight with Oprah's Nod

Updated Category News Views 69

Oprah's Golden Touch: 30 Years Strong Every year, there are a few select spots that brands covet like a hawk on a rabbit hunt. Getting on Oprah’s 'Favorite Things' list is surely one of them. Just like that, the MacKenzie-Childs Electric Salt and Pepper Grinder Set has muscled its way into the 2026 selection. Spare me the bells and whistles; this is like hitting the...

Continue Reading
Norris Lake's New Kayak Fleet Propels Tourism Efforts

Updated Category News Views 120

Norris Lake Doubles Down on Water Adventures The winds of change are paddling through Norris Dam State Park as they've launched a new fleet of shiny kayaks, hoping to lure more adventure seekers into the heart of Tennessee. These ain't just boats; they're part of a bigger play by local tourism honchos hungry to pump some adrenaline—and dollars—back into the area. A...

Continue Reading
S&P Global's Bold $2 Billion Debt Offering Details

Updated Category News Views 80

Drilling Down into S&P Global's Debt Move S&P Global's throwing its hat in the ring with a colossal $2 billion debt offering. Now, they aren't just setting it on the table — they're notably carving it up into three chunks. You’ve got $750 million at 5.600% that comes due in 2031, $600 million at 5.800% for 2034, and $650 million at a 6.000% rate maturing in 2036....

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 125

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading

Top 5 Most Recently Viewed Articles

Preliminary Ratings Issued by KBRA for Upstart Securitization Trust

Updated Category News Views 388

Preliminary Ratings by KBRA for Upstart Securitization Trust 2024-1 KBRA recently assigned preliminary ratings to the three classes of notes issued by Upstart Securitization Trust 2024-1, also known as UPST 2024-1. This securitization involves a notable value of $208.001 million, primarily revolving around unsecured consumer loans. Details of the Ratings The assigned...

Continue Reading
Alchemy Pay Expands With Mississippi License Milestone

Updated Category News Views 247

Alchemy Pay's Latest Regulatory Push Well, here's something to chew on—Alchemy Pay, that stalwart in the fiat-crypto payment arena, just nabbed a Money Transmitter License down in Mississippi. Good move, because this means they've got their hands now in 20 states across the U.S. Quite a feat for a company out of Hong Kong looking to make waves in the regulatory ocean....

Continue Reading
Optimi Health Steps Up with Microdose Psilocybin

Updated Category News Views 27

New Horizons in the World of Psychedelics Optimi Health has just dropped a noteworthy update, and it's not something to ignore if you're keeping an eye on the psychedelic sector. They're rolling out microdose psilocybin products — a move that’s poised to stir the waters in clinical research. With dosages standardized at 1mg and 2mg, Optimi is targeting the need for...

Continue Reading
PowerBank Corporation Sees Stock Surge After Funding News

Updated Category News Views 111

PowerBank Corporation Stock Surge PowerBank Corporation (NASDAQ: SUUN) experienced significant stock gains recently, particularly on Wednesday. This rise came after the company announced an initial payment of $4 million for its solar projects, including Elmira, Jordan Road 1, and Jordan Road 2. This financial boost has attracted investor interest and propelled the stock...

Continue Reading
Lazard's Q3 2026: Surging Revenue, Waning Net Income

Updated Category News Views 88

Breaking Down the Numbers Lazard just dropped its Q3 2026 earnings report, and you can smell both optimism and caution in the air. Sure, $814 million in net revenue isn’t anything to sneeze at, especially when it’s a neat 9% jump from last year’s $748 million. Adjusted figures were a whisker away at $805 million. But dig deeper, and things get a tad less rosy—net...

Continue Reading